.5mg retatrutide GLP-3: RT Retatrutide 5mg — Retatrutide (LY3437943)

Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, risking fines, prosecution or prison

Several mechanisms may contribute: Rapid dietary restriction : GLP1 medications significantly reduce appetite, which can lead to a sharp drop in caloric intake

In fact, some early studies and patient reports indicate bloating and abdominal discomfort improve on GLP-1 therapy, likely due to the slowed, more gradual digestive process

It can feel like queasiness that lingers after eating, a general loss of interest in food, or a heaviness in your upper stomach